Kings Path Partners’s Johnson & Johnson JNJ Stock Holding History

Kings Path Partners’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$254K	Sell	958 -141	-13%	-$37.2K	0.07%	106
2026 Q2	$279K	Sell	1,099 -86	-7%	-$20K	0.07%	99
2026 Q1	$290K	Hold	1,185	–	–	0.1%	93
2025 Q4	$245K	Hold	1,185	–	–	0.09%	98
2025 Q3	$220K	Hold	1,185	–	–	0.08%	97
2025 Q2	$181K	Hold	1,185	–	–	0.07%	99
2025 Q1	$197K	Sell	1,185 -7,343	-86%	-$1.15M	0.1%	99
2024 Q4	$1.23M	Hold	8,528	–	–	0.53%	40
2024 Q3	$1.38M	Hold	8,528	–	–	0.58%	40
2024 Q2	$1.25M	Buy	+8,528	New	+$1.27M	0.59%	41

Other funds holding JNJ

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return

PineStone Asset Management Montreal, Quebec, Canada $15.4B AUM 14.92% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Kings Path Partners's JNJ Position: Q3 2026 in Review

Kings Path Partners reduced its Johnson & Johnson (JNJ) stake by 13% in Q3 2026, selling an estimated $37.2K and leaving 958 shares worth $254K. The position accounts for 0.07% of the portfolio, ranked #106.

Kings Path Partners first reported a position in JNJ in Q2 2024 and has held it in 10 quarters since. The position peaked at $1.38M in Q3 2024. 1,988 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

Kings Path Partners held 958 shares of Johnson & Johnson worth $254K as of Q3 2026.
Kings Path Partners sold 141 Johnson & Johnson shares in Q3 2026, an estimated $37.2K.
Johnson & Johnson made up 0.07% of Kings Path Partners's portfolio in Q3 2026, its #106 holding.
Kings Path Partners first reported a position in Johnson & Johnson in Q2 2024 and has held it in 10 quarters since.
Kings Path Partners's Johnson & Johnson position peaked at $1.38M in Q3 2024.
1,988 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Kings Path Partners's 13F filing for Q3 2026, filed 21 Oct 2026.